Aquestive Therapeutics Inc (AQST)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 57.07M | 61.29M | 56.99M | 59.45M | 57.42M | 129.52M | 117.61M | 109.96M |
流動資産合計 | 44.89M | 43.71M | 39.79M | 42.46M | 40.97M | 113.38M | 104.01M | 96.57M |
現金および同等物 | 27.27M | 26.88M | 22.44M | 24.92M | 23.87M | 95.2M | 89.87M | 77.89M |
非流動資産合計 | 16.27M | 21.39M | 21.81M | 21.54M | 20.63M | 20.19M | 17.52M | 17.24M |
負債合計 | 175.62M | 170.52M | 163.65M | 162.38M | 163.91M | 165.82M | 153.08M | 155.38M |
流動負債合計 | 39.53M | 40.38M | 38.65M | 24.06M | 18.31M | 18.06M | 13.9M | 15.15M |
非流動負債合計 | 169.54M | 155.33M | 145.79M | 172.87M | 173.11M | 176.53M | 169.2M | 171.48M |
普通株 | 55k | 56k | 62k | 67k | 69k | 90k | 91k | 91k |
留保所得 | -311.21M | -303.14M | -308.93M | -310.97M | -319.08M | -331.91M | -334.65M | -346.16M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 39.39M | 43.12M | 86.85M | 78.48M | 62.88M | 61.99M | 57.07M | 57.42M |
流動資産合計 | 23.33M | 28.16M | 74.2M | 68.31M | 44.63M | 47.26M | 44.89M | 40.97M |
現金および同等物 | 9.21M | 17.38M | 60.6M | 49.33M | 31.81M | 28.02M | 27.27M | 23.87M |
非流動資産合計 | -57.2M | -68.6M | 10.08M | -6.12M | -48.5M | -82.13M | -118.55M | -106.49M |
負債合計 | 56.97M | 69.61M | 76.77M | 84.6M | 111.38M | 144.13M | 175.62M | 163.91M |
流動負債合計 | 10.81M | 15.35M | 32.95M | 18.56M | 21.1M | 21.96M | 39.53M | 18.31M |
非流動負債合計 | 84.81M | 99.77M | 86.42M | 126.38M | 124.61M | 173.71M | 169.54M | 173.11M |
総資本 | -57.2M | -68.6M | 10.08M | -6.12M | -48.5M | -82.13M | -118.55M | -106.49M |
普通株 | 50.01M | 51.5M | 25k | 34k | 35k | 41k | 55k | 69k |
留保所得 | -108.67M | -120.09M | -61.38M | -130.47M | -186.26M | -256.8M | -311.21M | -319.08M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約